Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity

Anti-CD138-Targeted Interferon Is a Potent Therapeutic Against Multiple Myeloma

(2015) Esther M. Yoo et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses

(2014) Xuanming Yang et al.   CANCER CELL

CD38 and bone marrow microenvironment

(2014) Antonella Chillemi   Frontiers in Bioscience-Landmark

High efficiency cell-specific targeting of cytokine activity

(2014) Geneviève Garcin et al.   Nature Communications

Saturable human neopterin response to interferon-α assessed by a pharmacokinetic-pharmacodynamic model

(2013) Sangil Jeon et al.   Journal of Translational Medicine

Pharmacokinetics and Tissue Disposition of Lenalidomide in Mice

(2012) Darlene M. Rozewski et al.   AAPS Journal

Immunocytokines: a novel class of potent armed antibodies

(2012) Nadine Pasche et al.   DRUG DISCOVERY TODAY

CD19−CD45low/−CD38high/CD138+ plasma cells enrich for human tumorigenic myeloma cells

(2012) D Kim et al.   LEUKEMIA

Preclinical studies on targeted delivery of multiple IFN 2b to HLA-DR in diverse hematologic cancers

(2011) E. A. Rossi et al.   BLOOD

Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation

(2011) Katharina Frey et al.   Integrative Biology

Recent advances on the immunomodulatory effects of IFN-α: Implications for cancer immunotherapy and autoimmunity

(2010) Paola Rizza et al.   AUTOIMMUNITY

Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma

(2010) C. Xuan et al.   BLOOD

Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors

(2010) M. de Weers et al.   JOURNAL OF IMMUNOLOGY

CD20-targeted tetrameric interferon- , a novel and potent immunocytokine for the therapy of B-cell lymphomas

(2009) E. A. Rossi et al.   BLOOD

Multiple myeloma

(2009) Marc S Raab et al.   LANCET

Clinical uses of interferons

(2008) Robert M. Friedman   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY